Similar articles

• [Biological and immunological markers in acute leukaemia (author's transl)].

  López Borrasca A, González M, Hernández F, Ledesma M, Corrales A, San Miguel J. López Borrasca A, et al. Sangre (Barc). 1981;26(5B):756-82. Sangre (Barc). 1981. PMID: 6275558 Review. Spanish. No abstract available.
• [Enzymes of purine metabolism in thymic subpopulations defined by lectins].

  Jiménez Herráez MC, Larrocha C, Fernández de Castro M, Viloria A, Fernández-Chacón JL, García-Rodríguez MC. Jiménez Herráez MC, et al. Sangre (Barc). 1986;31(5):545-9. Sangre (Barc). 1986. PMID: 3027906 Spanish. No abstract available.
• Current concepts. Biochemical markers in lymphoid malignancy.

  Blatt J, Reaman G, Poplack DG. Blatt J, et al. N Engl J Med. 1980 Oct 16;303(16):918-22. doi: 10.1056/NEJM198010163031606. N Engl J Med. 1980. PMID: 6251368 Review. No abstract available.
• Enzyme markers in acute leukemias: advances during the last decade.

  Drexler HG, Gaedicke G, Minowada J. Drexler HG, et al. J Natl Cancer Inst. 1984 Jun;72(6):1283-98. J Natl Cancer Inst. 1984. PMID: 6328091 Review.
• The activities of enzymes of purine metabolism in murine thymus dependent lymphocytes.

  Sidi Y, Livne P, Brosh S, Pecht M, Shilder D, Pinkhas J, Trainin N, Sperling O. Sidi Y, et al. Biomed Pharmacother. 1984;38(9-10):455-8. Biomed Pharmacother. 1984. PMID: 6099152